Treatment with STS may preserve erectile function by elevating the H2S formation and H2S-generating enzyme expression and enhancing antioxidant capacity via the Nrf2/HO-1 pathway in rats with hyperlipidemia. Here, NFE2L2 is linked to hyperlipidemia.